VolitionRX Ltd (VNRX)
$0.20-4.76%Close
SELLCRISIS · day 94
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2M
- Beta
- 1.09
- P/E (TTM)
- -0.06
- Short % float
- 11.66%
- Days to cover
- 1.0
- SI change
- +19.1%
- 1W
- -13.04%
- 1M
- -35.48%
- vs SPY 1W
- -13.47%
- vs SPY 1M
- -37.54%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on VNRX?
- LOPJLB’s latest quantitative signal on VolitionRX Ltd (VNRX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is VNRX in?
- VolitionRX Ltd (VNRX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does VolitionRX Ltd (VNRX) do?
- VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucle…